Martingale Asset Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Buy |
+12,139
| New | +$395K | 0.01% | 657 |
|
|
2024
Q4 | – | Sell |
-15,605
| Closed | -$1.78M | – | 832 |
|
|
2024
Q3 | $1.78M | Sell |
15,605
-1,664
| -10% | -$190K | 0.04% | 342 |
|
|
2024
Q2 | $1.3M | Buy |
17,269
+1,429
| +9% | +$108K | 0.03% | 393 |
|
|
2024
Q1 | $1.08M | Sell |
15,840
-3
| -0% | -$205 | 0.02% | 452 |
|
|
2023
Q4 | $995K | Buy |
+15,843
| New | +$995K | 0.02% | 449 |
|
|
2022
Q4 | – | Sell |
-33,513
| Closed | -$806K | – | 870 |
|
|
2022
Q3 | $806K | Buy |
+33,513
| New | +$806K | 0.02% | 497 |
|